Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Ohio State University Wexner Medical Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Ohio State University Wexner Medical Center brings 4 presentations to ASH 2026 in New Orleans. Its program centres on autoimmune hemolytic anemia, sickle cell gene therapy and TP53 cancers. Work includes mycophenolate in warm autoimmune hemolytic anemia and expanding access to therapies for underserved groups.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Academic medical center of The Ohio State University in Columbus.
Session
Fri Dec 11
3:00pm–6:00pm
Scientific Workshop on TP53: A Moving Target
Mutations in the p53 gene bring a very poor outlook in myeloid cancers, and this workshop follows them from first mutation to therapy.
Leukemias
Session
Fri Dec 11
4:55pm–5:55pm
Discovering Novel Therapeutics and Future Research
Current and emerging treatments for p53-mutated disease, including immune approaches, resistance, and what separates responders from non-responders.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ohio State University Wexner Medical Center

Tell us what you sell and we’ll find the people at Ohio State University Wexner Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction